Stempoint Capital »

Boston Scientific Corporation shares owned by Stempoint Capital

Quarter-by-quarter ownership of Boston Scientific Corporation (BSX) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Boston Scientific Corporation

Tip: Access up to 7 years of quarterly data

All positions including Boston Scientific Corporation held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boston Scientific Corporation by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $13k 250k 0.05

More positions owned by Stempoint Capital

Abivax Sa Sponsored Ads (ABVX)
Abivax Sa Sponsored Ads (ABVX)
Praxis Precision Medicines I Com New (PRAX)
Praxis Precision Medicines I Com New (PRAX)
Surrozen Com New (SRZN)
Mbx Biosciences (MBX)
Mbx Biosciences (MBX)
Mineralys Therapeutics (MLYS)
Mineralys Therapeutics (MLYS)
Enliven Therapeutics (ELVN)
Enliven Therapeutics (ELVN)
Cg Oncology (CGON)
Cg Oncology (CGON)
Biohaven (BHVN)
Biohaven (BHVN)

View all positions for Stempoint Capital

Top funds holding Boston Scientific Corporation

Vanguard Group
BlackRock
FMR
Vanguard Capital Management
State Street Corporation
Geode Capital Management
PRIMECAP Management Company
Vanguard Portfolio Management
D. E. Shaw & Co
Bank of America Corporation
Morgan Stanley
Goldman Sachs Group
Bollard
Henderson Group
UBS Group

View all funds holding Boston Scientific Corporation